Yes, this-is-absolutely-a-validating 10Q for $PXYN and for Praxsyn shareholders... The company is still extremely profitable, and growing, and will report exceptional NET PROFITS for the entire 2015 year, it is obvious. Also, the company is an unqualified REVERSE MERGER success story, and the stock is verified even more UNDERVALUED now than ever....